Efficacy of oral palonosetron compared to intravenous palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: a phase 3 trial-Reference-Cited by-同舟云学术

Efficacy of oral palonosetron compared to intravenous palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: a phase 3 trial

Published:2013-01-26 Issue:5 Volume:21 Page:1453-1460
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Boccia Ralph,Grunberg Steven,Franco-Gonzales Edwin,Rubenstein Edward,Voisin Daniel

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00520-012-1691-5.pdf

Reference9 articles.

1. Martin CG, Rubenstein EB, Elting LS, Kim YJ, Osoba D (2003) Measuring chemotherapy-induced nausea and emesis. Cancer 89:645–655

2. Roila F, Hesketh PJ, Herrstedt J (2006) Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference. Ann Oncol 17:20–28

3. Navari RM (2006) Palonosetron: a second-generation 5-hydroxytryptamine receptor antagonist. Future Oncol 2:591–602

4. Eisenberg P, Figueroa-Vadillo J, Zamora R, Charu V, Hajdenberg J, Cartmell A et al (2003) Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase III, single-dose trial versus dolasetron. Cancer 98:2473–2482

5. Gralla R, Lichinitser M, Van DV, Sleeboom H, Mezger J, Peschel C et al (2003) Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron. Ann Oncol 14:1570–1577

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real hopes in antiemetic therapy;Meditsinskiy sovet = Medical Council;2024-07-25

2. The role of NEPA, a combination of netupitant and palonosetron, in the prevention of nausea and vomiting: case report and literature review;Meditsinskiy sovet = Medical Council;2023-07-28

3. Design and Development of Matrix Diffusion Control Transdermal Drug Delivery System for Antiemetic Drug;Research Journal of Pharmacy and Technology;2023-07-24

4. How Compounding Pharmacies Fill Critical Gaps in Pediatric Drug Development Processes: Suggested Regulatory Changes to Meet Future Challenges;Children;2022-12-01

5. Effect of Palonosetron on Physical Symptoms of Surgical Patients: A Systematic Review and Meta-Analysis;Computational and Mathematical Methods in Medicine;2022-03-27